Yoseph Shaaltiel - Net Worth and Insider Trading
Yoseph Shaaltiel Net Worth
The estimated net worth of Yoseph Shaaltiel is at least $53,331 dollars as of 2024-04-28. Yoseph Shaaltiel is the Executive VP, R&D of Protalix BioTherapeutics Inc and owns about 46,375 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $53,331. Details can be seen in Yoseph Shaaltiel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yoseph Shaaltiel has not made any transactions after 2012-05-02 and currently still holds the listed stock(s).
Transaction Summary of Yoseph Shaaltiel
Yoseph Shaaltiel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yoseph Shaaltiel owns 1 companies in total, including Protalix BioTherapeutics Inc (PLX) .
Click here to see the complete history of Yoseph Shaaltiel’s form 4 insider trades.
Insider Ownership Summary of Yoseph Shaaltiel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2012-05-02 | director & Executive VP & R&D |
Yoseph Shaaltiel Latest Holdings Summary
Yoseph Shaaltiel currently owns a total of 1 stock. Yoseph Shaaltiel owns 46,375 shares of Protalix BioTherapeutics Inc (PLX) as of May 2, 2012, with a value of $53,331.
Latest Holdings of Yoseph Shaaltiel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2012-05-02 | 46,375 | 1.15 | 53,331 |
Holding Weightings of Yoseph Shaaltiel
Yoseph Shaaltiel Form 4 Trading Tracker
According to the SEC Form 4 filings, Yoseph Shaaltiel has made a total of 0 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years. The most-recent trade in Protalix BioTherapeutics Inc is the sale of 30,000 shares on May 2, 2012, which brought Yoseph Shaaltiel around $2 Million.
Insider Trading History of Yoseph Shaaltiel
- 1
Yoseph Shaaltiel Trading Performance
GuruFocus tracks the stock performance after each of Yoseph Shaaltiel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yoseph Shaaltiel is -12.69%. GuruFocus also compares Yoseph Shaaltiel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yoseph Shaaltiel within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yoseph Shaaltiel's insider trading performs compared to the benchmark.
Performance of Yoseph Shaaltiel
Average Return
-49.75%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.32 | -12.69 | 5.36 | -49.75 | 45.68 | 37.75 |
| Relative Return to S&P 500(%) | 2.56 | -2.28 | 11.87 | -9.89 | 58.98 | 43.39 |
Yoseph Shaaltiel Ownership Network
Ownership Network List of Yoseph Shaaltiel
Ownership Network Relation of Yoseph Shaaltiel
Yoseph Shaaltiel Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
Yoseph Shaaltiel is the director & Executive VP & R&D of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, Yoseph Shaaltiel made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 110,000 shares made by Aharon Schwartz , and a net purchase of 64,516 shares made by Dror Bashan .
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 174,516 shares were bought by its insiders, resulting in a net purchase of 174,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
Yoseph Shaaltiel Mailing Address
Above is the net worth, insider trading, and ownership report for Yoseph Shaaltiel. You might contact Yoseph Shaaltiel via mailing address: C/o Protalix Biotherapeutics, Inc., 2 Snunit St, Science Park, Pob 455, Carmiel L3 20100.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
